Clinical Trial Update: VICTOR Study - A Study of Valcyte (Valganciclovir po) Compared to Ganciclovir iv in Patients With Cytomegalovirus (CMV) Disease Who Are Solid Organ Transplant Recipients [Phase 4]

View source ↗

Summary

A Phase 4 trial (VICTOR study) comparing oral valganciclovir (Valcyte) with intravenous ganciclovir in CMV disease among solid organ transplant recipients has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections

Drugs mentioned

• GANCICLOVIR (GANCICLOVIR SODIUM)
• Valcyte (valganciclovir)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Cytomegalovirus Infections | Phase 4 | Status: COMPLETED